<?xml version='1.0' encoding='utf-8'?>
<document id="26446447"><sentence text="Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma."><entity charOffset="22-32" id="DDI-PubMed.26446447.s1.e0" text="paclitaxel" /><entity charOffset="71-82" id="DDI-PubMed.26446447.s1.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.26446447.s1.e0" e2="DDI-PubMed.26446447.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s1.e0" e2="DDI-PubMed.26446447.s1.e1" /></sentence><sentence text="The aim of the present case report was to describe a novel pharmacokinetic drug–drug interaction between the antiplatelet agent clopidogrel and the antineoplastic agent paclitaxel"><entity charOffset="128-139" id="DDI-PubMed.26446447.s2.e0" text="clopidogrel" /><entity charOffset="169-179" id="DDI-PubMed.26446447.s2.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.26446447.s2.e0" e2="DDI-PubMed.26446447.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s2.e0" e2="DDI-PubMed.26446447.s2.e1" /></sentence><sentence text="" /><sentence text="The patient was identified in a previously described cohort of 93 patients with ovarian carcinoma treated with paclitaxel"><entity charOffset="111-121" id="DDI-PubMed.26446447.s4.e0" text="paclitaxel" /></sentence><sentence text=" The effect of clopidogrel acyl-β-D-glucuronide on the metabolism of paclitaxel was assessed in human liver microsomes"><entity charOffset="15-47" id="DDI-PubMed.26446447.s5.e0" text="clopidogrel acyl-β-D-glucuronide" /><entity charOffset="69-79" id="DDI-PubMed.26446447.s5.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.26446447.s5.e0" e2="DDI-PubMed.26446447.s5.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s5.e0" e2="DDI-PubMed.26446447.s5.e1" /></sentence><sentence text=" The analysis of clopidogrel in plasma and the quantification of paclitaxel and 6-hydroxypaclitaxel in in vitro samples were performed by liquid chromatography tandem mass spectrometry"><entity charOffset="17-28" id="DDI-PubMed.26446447.s6.e0" text="clopidogrel" /><entity charOffset="65-75" id="DDI-PubMed.26446447.s6.e1" text="paclitaxel" /><entity charOffset="80-99" id="DDI-PubMed.26446447.s6.e2" text="6-hydroxypaclitaxel" /><pair ddi="false" e1="DDI-PubMed.26446447.s6.e0" e2="DDI-PubMed.26446447.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s6.e0" e2="DDI-PubMed.26446447.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26446447.s6.e0" e2="DDI-PubMed.26446447.s6.e2" /><pair ddi="false" e1="DDI-PubMed.26446447.s6.e1" e2="DDI-PubMed.26446447.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26446447.s6.e1" e2="DDI-PubMed.26446447.s6.e2" /></sentence><sentence text="" /><sentence text="The patient was a 60-year-old female treated with an unknown dose of clopidogrel at the time of paclitaxel therapy"><entity charOffset="69-80" id="DDI-PubMed.26446447.s8.e0" text="clopidogrel" /><entity charOffset="96-106" id="DDI-PubMed.26446447.s8.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.26446447.s8.e0" e2="DDI-PubMed.26446447.s8.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s8.e0" e2="DDI-PubMed.26446447.s8.e1" /></sentence><sentence text=" Clopidogrel was present in all three of the plasma samples obtained during paclitaxel dosing"><entity charOffset="1-12" id="DDI-PubMed.26446447.s9.e0" text="Clopidogrel" /><entity charOffset="76-86" id="DDI-PubMed.26446447.s9.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.26446447.s9.e0" e2="DDI-PubMed.26446447.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s9.e0" e2="DDI-PubMed.26446447.s9.e1" /></sentence><sentence text=" Estimated unbound paclitaxel clearance was 238 l h−1, which was only 62% of the cohort geometric mean (385 l h−1; range 176–726)"><entity charOffset="19-29" id="DDI-PubMed.26446447.s10.e0" text="paclitaxel" /></sentence><sentence text=" She was hospitalized three times, developed severe neuropathy and paclitaxel treatment was subsequently discontinued"><entity charOffset="67-77" id="DDI-PubMed.26446447.s11.e0" text="paclitaxel" /></sentence><sentence text=" In vitro, 30-min preincubation with 100 μM clopidogrel acyl-β-D-glucuronide inhibited the depletion rate of 0"><entity charOffset="44-76" id="DDI-PubMed.26446447.s12.e0" text="clopidogrel acyl-β-D-glucuronide" /></sentence><sentence text="5 μM paclitaxel by 51% and the formation rate of 6-hydroxypaclitaxel by 77%"><entity charOffset="0-15" id="DDI-PubMed.26446447.s13.e0" text="5 μM paclitaxel" /><entity charOffset="49-68" id="DDI-PubMed.26446447.s13.e1" text="6-hydroxypaclitaxel" /><pair ddi="false" e1="DDI-PubMed.26446447.s13.e0" e2="DDI-PubMed.26446447.s13.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s13.e0" e2="DDI-PubMed.26446447.s13.e1" /></sentence><sentence text="" /><sentence text="This is the first report of a clopidogrel–paclitaxel interaction, suggesting that clinically used doses of clopidogrel can reduce the cytochrome P450 2C8 (CYP2C8)-mediated systemic clearance of paclitaxel, leading to an increased risk of paclitaxel toxicity"><entity charOffset="30-52" id="DDI-PubMed.26446447.s15.e0" text="clopidogrel–paclitaxel" /><entity charOffset="107-118" id="DDI-PubMed.26446447.s15.e1" text="clopidogrel" /><entity charOffset="194-204" id="DDI-PubMed.26446447.s15.e2" text="paclitaxel" /><entity charOffset="238-248" id="DDI-PubMed.26446447.s15.e3" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e0" e2="DDI-PubMed.26446447.s15.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e0" e2="DDI-PubMed.26446447.s15.e1" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e0" e2="DDI-PubMed.26446447.s15.e2" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e0" e2="DDI-PubMed.26446447.s15.e3" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e1" e2="DDI-PubMed.26446447.s15.e1" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e1" e2="DDI-PubMed.26446447.s15.e2" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e1" e2="DDI-PubMed.26446447.s15.e3" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e2" e2="DDI-PubMed.26446447.s15.e2" /><pair ddi="false" e1="DDI-PubMed.26446447.s15.e2" e2="DDI-PubMed.26446447.s15.e3" /></sentence><sentence text=" Caution should be exercised whenever the simultaneous use of paclitaxel and clopidogrel cannot be avoided"><entity charOffset="62-72" id="DDI-PubMed.26446447.s16.e0" text="paclitaxel" /><entity charOffset="77-88" id="DDI-PubMed.26446447.s16.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.26446447.s16.e0" e2="DDI-PubMed.26446447.s16.e0" /><pair ddi="false" e1="DDI-PubMed.26446447.s16.e0" e2="DDI-PubMed.26446447.s16.e1" /></sentence><sentence text="" /></document>